Adenocarcinoma is a malignant type of cancer that develops from glandular tissue and originates from mucus- or secretion-producing cells. It most commonly occurs in organs such as the lungs, stomach, pancreas, colon, and prostate. The disease progresses through uncontrolled cell proliferation and, if not diagnosed early, can spread to surrounding tissues and distant organs.<\/p>\n
The symptoms of adenocarcinoma vary depending on the affected organ. When it develops in the lungs, it may cause a persistent cough, shortness of breath, and chest pain, whereas intestinal adenocarcinoma may present with changes in bowel habits, abdominal pain, and weight loss. Fatigue and loss of appetite are also common in advanced stages.<\/p>\n
The diagnosis of adenocarcinoma is established through imaging methods and pathological examination. Computed tomography, magnetic resonance imaging, and endoscopic evaluations are used to determine the location and extent of the tumor. A definitive diagnosis is usually confirmed by microscopic examination of a tissue sample obtained through biopsy.<\/p>\n
Treatment methods for adenocarcinoma are planned according to the stage of the disease, the organ involved, and the patient’s overall health status. Surgery, chemotherapy, radiotherapy, and targeted therapies are the most commonly used treatment approaches. In cases diagnosed at an early stage, treatment success and survival rates can increase significantly.<\/p>\n
| What You Need to Know<\/td>\n | Information<\/td>\n<\/tr>\n |
| Definition of the Disease<\/td>\n | Adenocarcinoma is a malignant (cancerous) tumor that develops from glandular cells and typically affects mucus-producing cells. It can occur in various organs, including the lungs, colon, stomach, pancreas, prostate, breast, and others.<\/td>\n<\/tr>\n |
| Common Sites<\/td>\n | It is most commonly found in the lungs, colon (large intestine), stomach, pancreas, prostate, and breast tissue.<\/td>\n<\/tr>\n |
| Risk Factors<\/td>\n | Genetic predisposition, smoking and alcohol use, obesity, advanced age, unhealthy dietary habits, chronic inflammation, and exposure to environmental toxins.<\/td>\n<\/tr>\n |
| Symptoms (General)<\/td>\n | – Unexplained weight loss – Weakness and fatigue – Persistent pain – Bloody stool or sputum – Persistent cough or hoarseness – Abdominal pain, loss of appetite – Abdominal swelling or a palpable mass – Jaundice (in pancreatic adenocarcinoma)<\/td>\n<\/tr>\n |
| Symptoms (Organ-Specific)<\/td>\n | – Lung: Persistent cough, bloody sputum, shortness of breath – Colon: Changes in bowel habits, blood in the stool – Stomach: Stomach pain, early satiety, weight loss – Pancreas: Back pain, jaundice, weight loss – Prostate: Difficulty urinating, pelvic pain – Breast: Lump, nipple discharge, or nipple retraction<\/td>\n<\/tr>\n |
| Diagnostic Methods<\/td>\n | – Physical examination – Blood tests – Biopsy – Imaging methods: CT (Computed Tomography), MRI, PET scans, endoscopy, colonoscopy – Tumor markers (especially those specific to certain organs)<\/td>\n<\/tr>\n |
| Treatment Methods<\/td>\n | – Surgical intervention (removal of the tumor in early-stage disease) – Chemotherapy – Radiotherapy – Targeted therapy – Immunotherapy (particularly for certain lung and colon adenocarcinomas) – Palliative care (to manage symptoms in advanced cases)<\/td>\n<\/tr>\n |
| Prognosis (Disease Course)<\/td>\n | It varies depending on the affected organ, the stage at diagnosis, and the response to treatment. Early diagnosis significantly improves treatment success.<\/td>\n<\/tr>\n |
| Follow-up and Monitoring<\/td>\n | Regular screening and follow-up tests are important to monitor for recurrence after treatment. Periodic evaluations are performed following treatment.<\/td>\n<\/tr>\n |
| Prevention<\/td>\n | Maintaining a healthy diet, avoiding smoking and alcohol, exercising regularly, participating in screening programs (especially for high-risk individuals), and minimizing environmental risk exposure.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n |